Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects

Coronavirus virus disease 2019 (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), actually considered as a global pandemic. The entry-point for SARS-CoV-2 is angiotensin converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4), wh...

詳細記述

保存先:
書誌詳細
出版年:Pulm Pharmacol Ther
主要な著者: Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Qusty, Naeem, Cruz-Martins, Natália, El-Saber Batiha, Gaber
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier Ltd. 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7955803/
https://ncbi.nlm.nih.gov/pubmed/33727066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pupt.2021.102008
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料